Insulet Corporation - Common Stock (NQ:PODD)

Curious about the S&P500 stocks that are in motion on Friday? Join us as we explore the top movers within the S&P500 index during today's session.

Topics Economy

Explore the top gainers and losers within the S&P500 index in today's session. ↗

November 21, 2025

Via Chartmill

Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. ↗

November 20, 2025

Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below.

Via Chartmill

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day

November 20, 2025

Insulet Corp (PODD) offers strong growth and profitability at a reasonable valuation. Its solid financial health makes it a top affordable growth stock.

Peering Into Insulet Corp's Recent Short Interest ↗

November 20, 2025

Via Benzinga

Insulet Corp (NASDAQ:PODD) Presents a Compelling Affordable Growth Opportunity ↗

November 20, 2025

Via Chartmill

$1000 Invested In Insulet 15 Years Ago Would Be Worth This Much Today ↗

November 19, 2025

Via Benzinga

3 Reasons We Love Insulet (PODD)

November 18, 2025

Since May 2025, Insulet has been in a holding pattern, posting a small return of 3% while floating around $335.74. The stock also fell short of the S&P 500’s 11.9% gain during that period.

Discover how Insulet Corp (PODD) combines strong technical uptrends with high-growth fundamentals, presenting a potential market leader for growth investors.

Topics Stocks

Insulet Corp (PODD) Shows Strong Technical and Fundamental Momentum ↗

November 18, 2025

Via Chartmill

1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds

November 11, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...

Discover how Insulet Corp exemplifies a powerful growth investing system, showcasing strong earnings, soaring sales, and impressive cash flow.

Topics Stocks

Insulet Corp (NASDAQ:PODD) Passes Stringent Growth Screen ↗

November 10, 2025

Via Chartmill

Gapping S&P500 stocks in Thursday's session ↗

November 06, 2025

Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Thursday. Stay informed about the latest market trends.

Via Chartmill

Insulet Rises As Broad Omnipod Growth Stokes Beat-And-Raise Quarter ↗

November 06, 2025

Insulet stock rose moderately early Thursday as its insulin pump, Omnipod, delivered double-digit growth in the U.S. and abroad.

Via Investor's Business Daily

Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗

November 06, 2025

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.

Via Chartmill

Insulet’s (NASDAQ:PODD) Q3: Strong Sales

November 06, 2025

Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 29.9% year on year to $706.3 million. On top of that, next...

Insulet Reports Third Quarter 2025 Results

November 06, 2025

Joseph Terranova of Virtus Investment Partners named Insulet Corp., a maker of wearable devices for insulin management, as his final trade.

Examining the Future: Insulet's Earnings Outlook ↗

November 05, 2025

Via Benzinga

Insulet, Uber And A Financial Stock On CNBC's 'Final Trades' ↗

November 05, 2025

Via Benzinga

Earnings To Watch: Insulet (PODD) Reports Q3 Results Tomorrow

November 04, 2025

Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be reporting results this Thursday before market hours. Here’s what investors should know.

Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month

Peering Into Insulet Corp's Recent Short Interest ↗

October 31, 2025

Via Benzinga

$100 Invested In Insulet 15 Years Ago Would Be Worth This Much Today ↗

October 30, 2025

Via Benzinga

October 30, 2025

Discover Insulet (PODD), a top growth stock with strong financials and a positive technical setup, making it a compelling pick for investors.

INSULET CORP (NASDAQ:PODD) Demonstrates Strong Growth and Technical Momentum ↗

October 29, 2025

Via Chartmill

1 Safe-and-Steady Stock to Own for Decades and 2 We Brush Off

October 27, 2025

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Insulet (PODD) is a GARP stock with strong revenue & earnings growth, solid profitability, and a reasonable valuation relative to its industry peers.

INSULET CORP (NASDAQ:PODD): A Prime Candidate for Affordable Growth Investing ↗

October 25, 2025

Via Chartmill

Insulet Announces Appointment of Robert L. Huffines to its Board of Directors

October 23, 2025

Discover how Louis Navellier's growth stock strategy identified Insulet Corp (PODD), a leader in innovative insulin delivery with strong earnings and sales growth.

Here's How Much You Would Have Made Owning Insulet Stock In The Last 10 Years ↗

October 21, 2025

Via Benzinga

Louis Navellier's Growth Strategy Highlights Insulet Corp (NASDAQ:PODD) ↗

October 20, 2025

Via Chartmill

Insulet to Host Investor Day on November 20, 2025

October 10, 2025